(Q57397131)

10

0 references

Cinzia Forleo

object named as

Cinzia Forleo

5

0 references

Giuseppe Bianchi

9

object named as

Giuseppe Bianchi

0 references

author name string

Maria Vittoria Pitzalis

1

0 references

John M. Hamlyn

2

0 references

Elisabetta Messaggio

3

0 references

Roberta Romito

6

0 references

Elisabetta de Tommasi

7

0 references

Paolo Rizzon

European Journal of Heart Failure

8

0 references

publication date

20 February 2006

0 references

published in

0 references

volume

8

0 references

page(s)

179-186

0 references

issue

2

0 references

cites work

Mechanisms and models in heart failure: A combinatorial approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Identification and characterization of a ouabain-like compound from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Salt, endogenous ouabain and blood pressure interactions in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Ouabain-like factor: is this the natriuretic hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Mode of death in chronic heart failure. A request and proposition for more accurate classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Brain "ouabain", a neurosteroid, mediates sympathetic hyperactivity in salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

The renal excretion of digoxin in the normal young subject

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Role of P-glycoprotein in drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Strategies for developing biomarkers of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Significance of predischarge BNP on one-year outcome in decompensated heart failure--comparative study with echo-Doppler indexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010

Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.07.010